Aktie BEACONPHAR BEACON PHARMACEUTICALS PLC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Beacon Pharmaceuticals PLC

Aktien

BEACONPHAR

BD0482BECON5

BEACONPHAR

Schlusskurs Dhaka S.E.
Andere Börsenplätze
 00:00:00 09.05.2024 		% 5 Tage % 1. Jan.
181,8 BDT -2,99 % Intraday Chart für Beacon Pharmaceuticals PLC -1,20 % -25,80 %
13.02. Beacon Pharmaceuticals PLC meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI
30.01. Beacon Pharmaceuticals plc gibt die Ernennung von Md. Sahabuddin FCS als Unternehmenssekretär CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Beacon Pharmaceuticals plc Announces Appointment of Md. Sahabuddin FCS as Company Secretary
Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023
Beacon Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended June 30, 2023
Beacon Pharmaceuticals plc Recommends Cash Dividend for the Year Ended June 30, 2023
Beacon Pharmaceuticals plc Appoints Mr. Ulfat Karim as the Director and Chief Operating Officer
Beacon Pharmaceuticals PLC Announces Appointment of Jalal Uddin as Chief Financial Officer
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as CFO
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as Director (Finance & Accounts)
Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Beacon Pharmaceuticals Limited will Change its Name to Beacon Pharmaceuticals PLC
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022
Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021
Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. BEACONPHAR Aktie
  4. Nachrichten Beacon Pharmaceuticals PLC
  5. Andere Sprachen